In support of this, although AD-diagnostic antibodies react with Tau monomers from Sf9 cells (see (14)), this is not per se an indicator of cell degeneration except in diseases such as AD and transgenic mice with Tau pathology. Here, MAPT is linked to Alzheimer disease.